395 related articles for article (PubMed ID: 17004352)
1. Use of androgens in patients who have HIV/AIDS: what we know about the effect of androgens on wasting and lipodystrophy.
Abrams D
AIDS Read; 2001 Mar; 11(3):149-56. PubMed ID: 17004352
[TBL] [Abstract][Full Text] [Related]
2. Wasting and lipodystrophy in patients infected with HIV: a practical approach in clinical practice.
Fisher K
AIDS Read; 2001 Mar; 11(3):132-3, 137-40, 147. PubMed ID: 17004351
[TBL] [Abstract][Full Text] [Related]
3. Testosterone replacement for hypogonadism: clinical findings and best practices.
Hengge UR
AIDS Read; 2003 Dec; 13(12 Suppl):S15-21. PubMed ID: 14959695
[TBL] [Abstract][Full Text] [Related]
4. The use of testosterone in the AIDS wasting syndrome.
Corcoran C; Grinspoon S
AIDS Clin Care; 1999 Apr; 11(4):25-6, 33-4. PubMed ID: 11366208
[TBL] [Abstract][Full Text] [Related]
5. Use of steroids for self-enhancement: an epidemiologic/societal perspective.
Yesalis CE
AIDS Read; 2001 Mar; 11(3):157-60. PubMed ID: 17004353
[TBL] [Abstract][Full Text] [Related]
6. Sustained anabolic effects of long-term androgen administration in men with AIDS wasting.
Grinspoon S; Corcoran C; Anderson E; Hubbard J; Stanley T; Basgoz N; Klibanski A
Clin Infect Dis; 1999 Mar; 28(3):634-6. PubMed ID: 10194091
[TBL] [Abstract][Full Text] [Related]
7. Testosterone metabolism and replacement therapy in patients with end-stage renal disease.
Johansen KL
Semin Dial; 2004; 17(3):202-8. PubMed ID: 15144546
[TBL] [Abstract][Full Text] [Related]
8. Use of steroids for wasting and lipodystrophy syndromes in HIV/AIDS.
Frost KR
AIDS Read; 2001 Mar; 11(3):130-1. PubMed ID: 17004350
[No Abstract] [Full Text] [Related]
9. Single-agent/combination therapy of human immunodeficiency virus-related wasting.
Wanke C
Semin Oncol; 1998 Apr; 25(2 Suppl 6):98-103. PubMed ID: 9625391
[TBL] [Abstract][Full Text] [Related]
10. The quality factor.
HIV Hotline; 1998 May; 8(2):1-6. PubMed ID: 11365361
[TBL] [Abstract][Full Text] [Related]
11. Effects of nandrolone decanoate compared with placebo or testosterone on HIV-associated wasting.
Gold J; Batterham MJ; Rekers H; Harms MK; Geurts TB; Helmyr PM; Silva de Mendonça J; Falleiros Carvalho LH; Panos G; Pinchera A; Aiuti F; Lee C; Horban A; Gatell J; Phanuphak P; Prasithsirikul W; Gazzard B; Bloch M; Danner SA;
HIV Med; 2006 Apr; 7(3):146-55. PubMed ID: 16494628
[TBL] [Abstract][Full Text] [Related]
12. Treatment of hypogonadism in men with chronic kidney disease.
Johansen KL
Adv Chronic Kidney Dis; 2004 Oct; 11(4):348-56. PubMed ID: 15492971
[TBL] [Abstract][Full Text] [Related]
13. Rationale, design and methods of the ESPRIT study: Energy, Sexual desire and body PropoRtions wIth AndroGel, Testosterone 1% gel therapy, in hypogonadal men.
Behre HM; Heinemann L; Morales A; Pexman-Fieth C
Aging Male; 2008 Jun; 11(2):101-6. PubMed ID: 18570063
[TBL] [Abstract][Full Text] [Related]
14. Wasting and body changes: what do we know so far?
Gomez E
Newsline People AIDS Coalit N Y; 1998 Sep; ():34-6. PubMed ID: 11367489
[TBL] [Abstract][Full Text] [Related]
15. Testosterone replacement therapy in hypogonadal men: assessing benefits, risks, and best practices.
Miner M; Canty DJ; Shabsigh R
Postgrad Med; 2008 Sep; 120(3):130-53. PubMed ID: 18824832
[TBL] [Abstract][Full Text] [Related]
16. Can androgen therapy replete lean body mass and improve muscle function in wasting associated with human immunodeficiency virus infection?
Bhasin S; Javanbakht M
JPEN J Parenter Enteral Nutr; 1999; 23(6 Suppl):S195-201. PubMed ID: 10571455
[TBL] [Abstract][Full Text] [Related]
17. Approaches to the AIDS Wasting Syndrome.
Corcoran C
Posit Dir News; 1998; 10(2):24-7. PubMed ID: 11365549
[TBL] [Abstract][Full Text] [Related]
18. Should androgenic anabolic steroids be considered in the treatment regime of selected chronic obstructive pulmonary disease patients?
Velema MS; Kwa BH; de Ronde W
Curr Opin Pulm Med; 2012 Mar; 18(2):118-24. PubMed ID: 22189453
[TBL] [Abstract][Full Text] [Related]
19. No attrition in research on wasting therapies.
Gilden D
GMHC Treat Issues; 1997; 11(4/5):9, 12-6. PubMed ID: 11364378
[TBL] [Abstract][Full Text] [Related]
20. Testosterone administration to men with testosterone deficiency syndrome after external beam radiotherapy for localized prostate cancer: preliminary observations.
Morales A; Black AM; Emerson LE
BJU Int; 2009 Jan; 103(1):62-4. PubMed ID: 18671790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
